• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

完美风暴：慢性阻塞性肺疾病遇上支气管扩张症

The perfect storm: when COPD meets bronchiectasis.

作者信息

Romero-Palacios Pedro J, Alcázar-Navarrete Bernardino

机构信息

Medicine Department, University of Granada, Granada, Spain.

Respiratory Department, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.

出版信息

ERJ Open Res. 2025 Mar 10;11(2). doi: 10.1183/23120541.01023-2024. eCollection 2025 Mar.

DOI:10.1183/23120541.01023-2024
PMID:40071271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11895097/
Abstract

https://bit.ly/3Z9qNOb.

摘要

https://bit.ly/3Z9qNOb. （此为网址，无法准确翻译其内容，保留原文形式）

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892c/11895097/b21bfe1bcc8c/01023-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892c/11895097/b21bfe1bcc8c/01023-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892c/11895097/b21bfe1bcc8c/01023-2024.01.jpg

相似文献

1
The perfect storm: when COPD meets bronchiectasis.完美风暴：慢性阻塞性肺疾病遇上支气管扩张症
ERJ Open Res. 2025 Mar 10;11(2). doi: 10.1183/23120541.01023-2024. eCollection 2025 Mar.
2
The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study.支气管扩张伴固定气流阻塞患者肺部微生物组的临床影响：一项前瞻性队列研究。
Respir Res. 2024 Aug 14;25(1):308. doi: 10.1186/s12931-024-02931-x.
3
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD.支气管扩张症、哮喘和慢性阻塞性肺疾病的医疗费用及资源利用情况。
ERJ Open Res. 2023 Jul 31;9(4). doi: 10.1183/23120541.00158-2023. eCollection 2023 Jul.
4
Elevated interleukin-6 and bronchiectasis as risk factors for acute exacerbation in patients with tuberculosis-destroyed lung with airflow limitation.白细胞介素-6升高和支气管扩张作为气流受限的结核毁损肺患者急性加重的危险因素。
J Thorac Dis. 2018 Sep;10(9):5246-5253. doi: 10.21037/jtd.2018.08.29.
5
The characteristics and prognosis of bronchiectasis patients with airflow limitation: a prospective longitudinal study.气流受限的支气管扩张症患者的特征与预后：一项前瞻性纵向研究
BMC Pulm Med. 2024 Dec 3;24(1):599. doi: 10.1186/s12890-024-03422-x.
6
High prevalence of bronchiectasis in emphysema-predominant COPD patients.以肺气肿为主的慢性阻塞性肺疾病患者中支气管扩张的高患病率。
Int J Chron Obstruct Pulmon Dis. 2018 Jun 27;13:2041-2047. doi: 10.2147/COPD.S163243. eCollection 2018.
7
Favorable Response to Long-Term Azithromycin Therapy in Bronchiectasis Patients with Chronic Airflow Obstruction Compared to Chronic Obstructive Pulmonary Disease Patients without Bronchiectasis.支气管扩张症伴慢性气流阻塞患者长期应用阿奇霉素治疗的疗效优于无支气管扩张症的慢性阻塞性肺疾病患者。
Int J Chron Obstruct Pulmon Dis. 2021 Mar 30;16:855-863. doi: 10.2147/COPD.S292297. eCollection 2021.
8
The Association between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC).支气管扩张症与慢性阻塞性肺疾病的相关性：来自欧洲支气管扩张症注册研究（EMBARC）的数据。
Am J Respir Crit Care Med. 2024 Jul 1;210(1):119-127. doi: 10.1164/rccm.202309-1614OC.
9
Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis.慢性阻塞性肺疾病合并支气管扩张患者脂联素水平升高。
Life (Basel). 2023 Feb 4;13(2):444. doi: 10.3390/life13020444.
10
Pulmonary function abnormalities in adult patients with acute exacerbation of bronchiectasis: A retrospective risk factor analysis.成人支气管扩张症急性加重患者的肺功能异常：一项回顾性危险因素分析。
Chron Respir Dis. 2015 Aug;12(3):222-9. doi: 10.1177/1479972315583042. Epub 2015 Apr 16.

本文引用的文献

1
Reexamining Chronic Obstructive Pulmonary Disease in Bronchiectasis: Elucidating Overdiagnosis and Outcomes from EMBARC's ROSE Criteria.重新审视支气管扩张症中的慢性阻塞性肺疾病：根据EMBARC的ROSE标准阐明过度诊断及预后情况。
Am J Respir Crit Care Med. 2024 Jul 15;210(2):247-248. doi: 10.1164/rccm.202402-0289LE.
2
The Association between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC).支气管扩张症与慢性阻塞性肺疾病的相关性：来自欧洲支气管扩张症注册研究（EMBARC）的数据。
Am J Respir Crit Care Med. 2024 Jul 1;210(1):119-127. doi: 10.1164/rccm.202309-1614OC.
3
Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries.
支气管扩张症：20年随访期间患者特征的变化。来自西班牙支气管扩张症登记处的数据。
Arch Bronconeumol. 2023 Oct;59(10):688-690. doi: 10.1016/j.arbres.2023.07.023. Epub 2023 Jul 27.
4
Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019.1990 - 2019年慢性呼吸道疾病及其风险因素的全球负担：全球疾病负担研究2019年的最新情况
EClinicalMedicine. 2023 May;59:101936. doi: 10.1016/j.eclinm.2023.101936.
5
Pathophysiology of Chronic Bronchial Infection in Bronchiectasis.支气管扩张症慢性支气管感染的病理生理学。
Arch Bronconeumol. 2023 Feb;59(2):101-108. doi: 10.1016/j.arbres.2022.09.004. Epub 2022 Sep 15.
6
Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the "Chronic Obstructive Pulmonary Disease-Bronchiectasis Association".慢性阻塞性肺疾病、支气管扩张症及“慢性阻塞性肺疾病-支气管扩张症关联”的表型分型
Am J Respir Crit Care Med. 2022 Aug 15;206(4):417-426. doi: 10.1164/rccm.202108-1943OC.
7
Pseudomonas aeruginosa Colonization and COPD: The Chicken or the Egg?铜绿假单胞菌定植与慢性阻塞性肺疾病：先有鸡还是先有蛋？
Arch Bronconeumol. 2022 Jul;58(7):539-541. doi: 10.1016/j.arbres.2021.12.001. Epub 2021 Dec 18.
8
Biological Biomarkers in Respiratory Diseases.生物标志物在呼吸疾病中的应用
Arch Bronconeumol. 2022 Apr;58(4):323-333. doi: 10.1016/j.arbres.2022.01.003. Epub 2022 Jan 17.
9
Treating Neutrophilic Inflammation in Airways Diseases.治疗气道疾病中的嗜中性粒细胞炎症
Arch Bronconeumol. 2022 Jun;58(6):463-465. doi: 10.1016/j.arbres.2021.11.003. Epub 2021 Nov 16.
10
ROSE: radiology, obstruction, symptoms and exposure - a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group.ROSE：放射学、阻塞、症状及暴露——EMBARC气道工作组对慢性阻塞性肺疾病与支气管扩张症关联的德尔菲共识定义
ERJ Open Res. 2021 Nov 22;7(4). doi: 10.1183/23120541.00399-2021. eCollection 2021 Oct.